Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins

Vascular Pharmacology

Volumn 42, Issue 3, 2005, Pages 125-140

  Asselbergs, Folkert W ^a,b   Van Der Harst, Pim ^a,b   Jessurun, Gillian A J ^b   Tio, René A ^b   Van Gilst, Wiek H ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ACE inhibitors; Acetylcholine; Endothelial function; Prognosis; Risk factors; Statins

Indexed keywords

AMLODIPINE; ATORVASTATIN; BENAZEPRIL; CAPTOPRIL; CERIVASTATIN; CILAZAPRIL; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRILAT; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; MEVINOLIN; N(G) NITROARGININE METHYL ESTER; PERINDOPRIL; PRAVASTATIN; PROBUCOL; QUINAPRIL; SIMVASTATIN; TEMOCAPRIL;

CARDIOVASCULAR RISK; CELL FUNCTION; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; FUNCTIONAL ASSESSMENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW; RISK ASSESSMENT; VASOMOTOR REFLEX;

EID: 15744367520     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.01.009     Document Type: Review

References (199)

1. E.W. Albrecht, C.A. Stegeman, P. Heeringa, R.H. Henning, and H. van Goor Protective role of endothelial nitric oxide synthase J. Pathol. 199 2003 8 17
2. G. Amoroso, R.A. Tio, M.A. Mariani, A.J. van Boven, G.A. Jessurun, S.H. Monnink, J.G. Grandjean, P.W. Boonstra, and H.J. Crijns Functional integrity and aging of the left internal thoracic artery after coronary artery bypass surgery J. Thorac. Cardiovasc. Surg. 120 2000 313 318
3. T.J. Anderson, I.T. Meredith, A.C. Yeung, B. Frei, A.P. Selwyn, and P. Ganz The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion N. Engl. J. Med. 332 1995 488 493
4. T.J. Anderson, A. Uehata, M.D. Gerhard, I.T. Meredith, S. Knab, D. Delagrange, E.H. Lieberman, P. Ganz, M.A. Creager, and A.C. Yeung Close relation of endothelial function in the human coronary and peripheral circulations J. Am. Coll. Cardiol. 26 1995 1235 1241
5. T.J. Anderson, E. Elstein, H. Haber, and F. Charbonneau Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) J. Am. Coll. Cardiol. 35 2000 60 66
6. T.C. Andrews, E.J. Whitney, G. Green, R. Kalenian, and B.E. Personius Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels (160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl Am. J. Cardiol. 80 1997 831 835
7. N.P. Andrews, A. Prasad, and A.A. Quyyumi N-acetylcysteine improves coronary and peripheral vascular function J. Am. Coll. Cardiol. 37 2001 117 123
8. I. Antony, E. Aptecar, G. Lerebours, and A. Nitenberg Coronary artery constriction caused by the cold pressor test in human hypertension Hypertension 24 1994 212 219
9. I. Antony, G. Lerebours, and A. Nitenberg Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients Circulation 94 1996 3115 3122
10. G. Arcaro, B.M. Zenere, F. Saggiani, M.G. Zenti, T. Monauni, A. Lechi, M. Muggeo, and R.C. Bonadonna ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria Diabetes Care 22 1999 1536 1542
11. F.W. Asselbergs, S.H. Monnink, G.A. Jessurun, A.J. van Boven, N.J. Veeger, F. Zijlstra, W.H. van Gilst, and R.A. Tio Assessing the prognostic value of coronary endothelial function in patients referred for a first coronary angiogram Am. J. Cardiol. 94 2004 1063 1067
12. A. Avogaro, M. Miola, A. Favaro, L. Gottardo, G. Pacini, E. Manzato, S. Zambon, D. Sacerdoti, S. de Kreutzenberg, T. Piliego, A. Tiengo, and S. Del Prato Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients Eur. J. Clin. Invest. 31 2001 603 609
13. J.H. Bae, E. Bassenge, H.J. Lee, K.R. Park, C.G. Park, K.Y. Park, M.S. Lee, and M. Schwemmer Impact of postprandial hypertriglyceridemia on vascular responses in patients with coronary artery disease: effects of ACE inhibitors and fibrates Atherosclerosis 158 2001 165 171
14. J.A. Beckman, J.K. Liao, S. Hurley, L.A. Garrett, D. Chui, D. Mitra, and M.A. Creager Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein Circ. Res. 95 2004 217 223
15. R.M. Bell, and D.M. Yellon Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J. Am. Coll. Cardiol. 41 2003 508 515
16. S. Benacerraf, C. Carville, S. Adnot, O. Montagne, S. Sediame, L. Belhassen, and J.L. Dubois-Rande Improvement of bradykinin endothelium-mediated vasodilation of forearm resistance circulation by quinaprilat in patients with coronary artery disease with or without left ventricular dysfunction J. Cardiovasc. Pharmacol. 34 1999 368 373
17. M.L. Bots, W.J. Remme, T.F. Luscher, and D.E. Grobbee PERindopril-function of the endothelium in coronary artery disease trial: the PERFECT study-sub study of EUROPA: rationale and design Cardiovasc. Drugs Ther. 16 2002 227 236
18. M. Bottcher, H.E. Botker, H. Sonne, T.T. Nielsen, and J. Czernin Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X Circulation 99 1999 1795 1801
19. G. Brevetti, A. Silvestro, V. Schiano, and M. Chiariello Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index Circulation 108 2003 2093 2098
20. J.E. Brush Jr., D.P. Faxon, S. Salmon, A.K. Jacobs, and T.J. Ryan Abnormal endothelium-dependent coronary vasomotion in hypertensive patients J. Am. Coll. Cardiol. 19 1992 809 815
21. R. Butler, A.D. Morris, B. Burchell, and A.D. Struthers DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans Hypertension 33 1999 1164 1168
22. R. Butler, A.D. Morris, and A.D. Struthers Lisinopril improves endothelial function in chronic cigarette smokers Clin. Sci. (Lond.) 101 2001 53 58
23. P.R. Casino, C.M. Kilcoyne, A.A. Quyyumi, J.M. Hoeg, and J.A. Panza The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients Circulation 88 1993 2541 2547
24. D.S. Celermajer, K.E. Sorensen, V.M. Gooch, D.J. Spiegelhalter, O.I. Miller, I.D. Sullivan, J.K. Lloyd, and J.E. Deanfield Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
25. S.Y. Chan, G.B. Mancini, L. Kuramoto, M. Schulzer, J. Frohlich, and A. Ignaszewski The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease J. Am. Coll. Cardiol. 42 2003 1037 1043
26. C. Cheetham, J. Collis, G. O'Driscoll, K. Stanton, R. Taylor, and D. Green Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes J. Am. Coll. Cardiol. 36 2000 1461 1466
27. P.J. Chowienczyk, G.F. Watts, J.R. Cockcroft, and J.M. Ritter Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia Lancet 340 1992 1430 1432
28. M. Clozel, H. Kuhn, and F. Hefti Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats Hypertension 16 1990 532 540
29. F. Cosentino, and T.F. Luscher Endothelial dysfunction in diabetes mellitus J. Cardiovasc. Pharmacol. 32 Suppl. 3 1998 S54 S61
30. M.A. Creager, and M.A. Roddy Effect of captopril and enalapril on endothelial function in hypertensive patients Hypertension 24 1994 499 505
31. M.A. Creager, J.P. Cooke, M.E. Mendelsohn, S.J. Gallagher, S.M. Coleman, J. Loscalzo, and V.J. Dzau Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans J. Clin. Invest. 86 1990 228 234
32. J. Davignon, and P. Ganz Role of endothelial dysfunction in atherosclerosis Circulation 109 2004 III27 III32
33. S. de Jongh, M.R. Lilien, R.J. op't, E.S. Stroes, H.D. Bakker, and J.J. Kastelein Early statin therapy restores endothelial function in children with familial hypercholesterolemia J. Am. Coll. Cardiol. 40 2002 2117 2121
34. P. Di Napoli, T.A. Antonio, A. Grilli, R. Spina, M. Felaco, A. Barsotti, and R. De Caterina Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts Cardiovasc. Res. 51 2001 283 293
35. G.K. Dogra, G.F. Watts, S. Herrmann, M.A. Thomas, and A.B. Irish Statin therapy improves brachial artery endothelial function in nephrotic syndrome Kidney Int. 62 2002 550 557
36. M.B. Draznin, R.M. Rapoport, and F. Murad Myosin light chain phosphorylation in contraction and relaxation of intact rat thoracic aorta Int. J. Biochem. 18 1986 917 928
37. H. Drexler, and A.M. Zeiher Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia Hypertension 18 1991 II90 II99
38. S.J. Duffy, R.C. O'Brien, G. New, R.W. Harper, and I.T. Meredith Effect of anti-oxidant treatment and cholesterol lowering on resting arterial tone, metabolic vasodilation and endothelial function in the human forearm: a randomized, placebo-controlled study Clin. Exp. Pharmacol. Physiol. 28 2001 409 418
39. J. Dupuis, J.C. Tardif, P. Cernacek, and P. Theroux Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial Circulation 99 1999 3227 3233
40. P.A. Economides, A. Caselli, E. Tiani, L. Khaodhiar, E.S. Horton, and A. Veves The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes J. Clin. Endocrinol. Metab. 89 2004 740 747
41. K. Egashira, Y. Hirooka, H. Kai, M. Sugimachi, S. Suzuki, T. Inou, and A. Takeshita Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia Circulation 89 1994 2519 2524
42. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of Coronary Endothelial function) Circulation 107 2003 422 428
43. I. Eskurza, D.R. Seals, C.A. DeSouza, and H. Tanaka Pharmacologic versus flow-mediated assessments of peripheral vascular endothelial vasodilatory function in humans Am. J. Cardiol. 88 2001 1067 1069
44. R.J. Esper, R. Machado, J. Vilarino, J.L. Cacharron, C.A. Ingino, C.A. Garcia Guinazu, E. Bereziuk, A.L. Bolano, and D.H. Suarez Endothelium-dependent responses in patients with hypercholesterolemic coronary artery disease under the effects of simvastatin and enalapril, either separately or combined Am. Heart J. 140 2000 684 689
45. R. Fathi, B. Haluska, N. Isbel, L. Short, and T.H. Marwick The relative importance of vascular structure and function in predicting cardiovascular events J. Am. Coll. Cardiol. 43 2004 616 623
46. K.M. Finta, M.J. Fischer, L. Lee, D. Gordon, B. Pitt, and R.C. Webb Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet Atherosclerosis 100 1993 149 156
47. I. Fleming, and R. Busse Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase Am. J. Physiol., Regul. Integr. Comp. Physiol. 284 2003 R1 R12
48. U. Forstermann, A. Mugge, U. Alheid, A. Haverich, and J.C. Frolich Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries Circ. Res. 62 1988 185 190
49. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
50. J.V. Gainer, J.D. Morrow, A. Loveland, D.J. King, and N.J. Brown Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects N. Engl. J. Med. 339 1998 1285 1292
51. J. Galle, A. Mulsch, R. Busse, and E. Bassenge Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor Arterioscler. Thromb. 11 1991 198 203
52. M. Gerhard, B.W. Walsh, A. Tawakol, E.A. Haley, S.J. Creager, E.W. Seely, P. Ganz, and M.A. Creager Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women Circulation 98 1998 1158 1163
53. S.P. Glasser, A.P. Selwyn, and P. Ganz Atherosclerosis: risk factors and the vascular endothelium Am. Heart J. 131 1996 379 384
54. N. Gokce, J.F. Keaney Jr., B. Frei, M. Holbrook, M. Olesiak, B.J. Zachariah, C. Leeuwenburgh, J.W. Heinecke, and J.A. Vita Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease Circulation 99 1999 3234 3240
55. N. Gokce, J.F. Keaney Jr., L.M. Hunter, M.T. Watkins, J.O. Menzoian, and J.A. Vita Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study Circulation 105 2002 1567 1572
56. N. Gokce, J.F. Keaney Jr., L.M. Hunter, M.T. Watkins, Z.S. Nedeljkovic, J.O. Menzoian, and J.A. Vita Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease J. Am. Coll. Cardiol. 41 2003 1769 1775
57. J.B. Gordon, P. Ganz, E.G. Nabel, R.D. Fish, J. Zebede, G.H. Mudge, R.W. Alexander, and A.P. Selwyn Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise J. Clin. Invest. 83 1989 1946 1952
58. W.E. Haefeli, L. Linder, and T.F. Luscher Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans Hypertension 30 1997 912 917
59. J.P.J. Halcox, W.H. Schenke, G. Zalos, R. Mincemoyer, A. Prasad, M.A. Waclawin, K.R.A. Nour, and A.A. Quyyumi Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658
60. R. Hambrecht, A. Wolf, S. Gielen, A. Linke, J. Hofer, S. Erbs, N. Schoene, and G. Schuler Effect of exercise on coronary endothelial function in patients with coronary artery disease N. Engl. J. Med. 342 2000 454 460
61. H. Hayakawa, K. Coffee, and L. Raij Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy Circulation 96 1997 2407 2413
62. T. Heitzer, S. Yla-Herttuala, J. Luoma, S. Kurz, T. Munzel, H. Just, M. Olschewski, and H. Drexler Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL Circulation 93 1996 1346 1353
63. T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, and T. Munzel Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease Circulation 104 2001 2673 2678
64. Y. Higashi, S. Sasaki, K. Nakagawa, T. Ueda, A. Yoshimizu, S. Kurisu, H. Matsuura, G. Kajiyama, and T. Oshima A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study J. Am. Coll. Cardiol. 35 2000 284 291
65. M.L. Hijmering, E.S. Stroes, G. Pasterkamp, M. Sierevogel, J.D. Banga, and T.J. Rabelink Variability of flow mediated dilation: consequences for clinical application Atherosclerosis 157 2001 369 373
66. Y. Hirooka, T. Imaizumi, H. Masaki, S. Ando, S. Harada, M. Momohara, and A. Takeshita Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients Hypertension 20 1992 175 180
67. F. Hofmann, A. Ammendola, and J. Schlossmann Rising behind NO: cGMP-dependent protein kinases J. Cell. Sci. 113 Pt 10 2000 1671 1676
68. D.E. Hokanson, D.S. Sumner, and D.E. Strandness Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow IEEE Trans. Biomed. Eng. 22 1975 25 29
69. S.M. Hollenberg, L.W. Klein, J.E. Parrillo, M. Scherer, D. Burns, P. Tamburro, M. Oberoi, M.R. Johnson, and M.R. Costanzo Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death Circulation 104 2001 3091 3096
70. B. Hornig, N. Arakawa, D. Haussmann, and H. Drexler Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure Circulation 98 1998 2842 2848
71. A.J. Houben, A.A. Kroon, C.H. de Haan, M.J. Fuss-Lejeune, and P.W. de Leeuw Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat Cardiovasc. Drugs Ther. 14 2000 657 663
72. J.L. Houghton, T.A. Pearson, R.G. Reed, M.T. Torosoff, N.L. Henches, P.A. Kuhner, and E.F. Philbin Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms Chest 118 2000 756 760
73. T. Hozumi, K. Yoshida, T. Akasaka, Y. Asami, Y. Ogata, T. Takagi, S. Kaji, T. Kawamoto, Y. Ueda, and S. Morioka Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique J. Am. Coll. Cardiol. 32 1998 1251 1259
74. S. Husain, N.P. Andrews, D. Mulcahy, J.A. Panza, and A.A. Quyyumi Aspirin improves endothelial dysfunction in atherosclerosis Circulation 97 1998 716 720
75. K. Igarashi, M. Tsuji, M. Nishimura, and M. Horimoto Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia J. Clin. Apher. 19 2004 11 16
76. K. Iiyama, M. Nagano, Y. Yo, N. Nagano, K. Kamide, J. Higaki, H. Mikami, and T. Ogihara Impaired endothelial function with essential hypertension assessed by ultrasonography Am. Heart J. 132 1996 779 782
77. S. Iliceto, V. Marangelli, C. Memmola, and P. Rizzon Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation Circulation 83 1991 61 69
78. H. Iwatsubo, M. Nagano, T. Sakai, K. Kumamoto, R. Morita, J. Higaki, T. Ogihara, and T. Hata Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension Hypertension 29 1997 286 290
79. M.J. Jarvisalo, J.O. Toikka, T. Vasankari, J. Mikkola, J.S. Viikari, J.J. Hartiala, and O.T. Raitakari HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease Atherosclerosis 147 1999 237 242
80. S. John, C. Delles, J. Jacobi, M.P. Schlaich, M. Schneider, G. Schmitz, and R.E. Schmieder Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks J. Am. Coll. Cardiol. 37 2001 1351 1358
81. W. Kiowski, L. Linder, R. Nuesch, and B. Martina Effects of angiotensin converting enzyme inhibition on endothelial vasodilator function in primary human hypertension Eur. Heart J. 14 Suppl. C 1993 5 9
82. J.T. Kuvin, A.R. Patel, K.A. Sliney, N.G. Pandian, W.M. Rand, J.E. Udelson, and R.H. Karas Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease J. Am. Coll. Cardiol. 38 2001 1843 1849
83. H. Lange, H. Suryapranata, G. De Luca, C. Borner, J. Dille, K. Kallmayer, M.N. Pasalary, E. Scherer, and J.H. Dambrink Folate therapy and in-stent restenosis after coronary stenting N. Engl. J. Med. 350 2004 2673 2681
84. U. Laufs Beyond lipid-lowering: effects of statins on endothelial nitric oxide Eur. J. Clin. Pharmacol. 58 2003 719 731
85. U. Laufs, K. Gertz, P. Huang, G. Nickenig, M. Bohm, U. Dirnagl, and M. Endres Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice Stroke 31 2000 2442 2449
86. U. Laufs, S. Wassmann, S. Hilgers, N. Ribaudo, M. Bohm, and G. Nickenig Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men Am. J. Cardiol. 88 2001 1306 1307
87. A.F. Lee, J.B. Dick, C.E. Bonnar, and A.D. Struthers Lisinopril improves arterial function in hyperlipidaemia Clin. Sci. (Lond.) 96 1999 441 448
88. W.H. Leung, C.P. Lau, and C.K. Wong Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients Lancet 341 1993 1496 1500
89. G.N. Levine, B. Frei, S.N. Koulouris, M.D. Gerhard, J.F. Keaney Jr., and J.A. Vita Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease Circulation 93 1996 1107 1113
90. J. Li, S.P. Zhao, X.P. Li, Q.C. Zhuo, M. Gao, and S.K. Lu Non-invasive detection of endothelial dysfunction in patients with essential hypertension Int. J. Cardiol. 61 1997 165 169
91. J.K. Liao Inhibition of Gi proteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide J. Biol. Chem. 269 1994 12987 12992
92. J.K. Liao Beyond lipid lowering: the role of statins in vascular protection Int. J. Cardiol. 86 2002 5 18
93. J.K. Liao, W.S. Shin, W.Y. Lee, and S.L. Clark Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase J. Biol. Chem. 270 1995 319 324
94. E.H. Lieberman, M.D. Gerhard, A. Uehata, B.W. Walsh, A.P. Selwyn, P. Ganz, A.C. Yeung, and M.A. Creager Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women Ann. Intern. Med. 121 1994 936 941
95. A. Liem, G.H. Reynierse-Buitenwerf, A.H. Zwinderman, J.W. Jukema, and D.J. van Veldhuisen Secondary prevention with folic acid: effects on clinical outcomes J. Am. Coll. Cardiol. 41 2003 2105 2113
96. T.M. Lincoln, N. Dey, and H. Sellak Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression J. Appl. Physiol. 91 2001 1421 1430
97. L. Lind, S.O. Granstam, and J. Millgard Endothelium-dependent vasodilation in hypertension: a review Blood Pressure 9 2000 4 15
98. L. Linder, W. Kiowski, F.R. Buhler, and T.F. Luscher Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension Circulation 81 1990 1762 1767
99. P.L. Ludmer, A.P. Selwyn, T.L. Shook, R.R. Wayne, G.H. Mudge, R.W. Alexander, and P. Ganz Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries N. Engl. J. Med. 315 1986 1046 1051
100. T.F. Luscher, and P.M. Vanhoutte The endothelium modulator of cardiovascular function 1990 CRC Press Boca Raton, FL
101. T.F. Luscher, D. Diederich, R. Siebenmann, K. Lehmann, P. Stulz, L. von Segesser, Z.H. Yang, M. Turina, E. Gradel, and E. Weber Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts N. Engl. J. Med. 319 1988 462 467
102. S. Makimattila, M.L. Liu, J. Vakkilainen, A. Schlenzka, S. Lahdenpera, M. Syvanne, M. Mantysaari, P. Summanen, R. Bergholm, M.R. Taskinen, and H. Yki-Jarvinen Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants Diabetes Care 22 1999 973 981
103. J. Malik, V. Melenovsky, D. Wichterle, T. Haas, J. Simek, R. Ceska, and J. Hradec Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial-FAT) Cardiovasc. Res. 52 2001 290 298
104. G.B. Mancini, G.C. Henry, C. Macaya, B.J. O'Neill, A.L. Pucillo, R.G. Carere, T.J. Wargovich, H. Mudra, T.F. Luscher, M.I. Klibaner, H.E. Haber, A.C. Uprichard, C.J. Pepine, and B. Pitt Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) study Circulation 94 1996 258 265
105. M.A. Marletta Nitric oxide synthase structure and mechanism J. Biol. Chem. 268 1993 12231 12234
106. A. Masumoto, Y. Hirooka, K. Hironaga, K. Eshima, S. Setoguchi, K. Egashira, and A. Takeshita Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin) Am. J. Cardiol. 88 2001 1291 1294
107. R. McFarlane, R.J. McCredie, M.A. Bonney, L. Molyneaux, R. Zilkens, D.S. Celermajer, and D.K. Yue Angiotensin converting enzyme inhibition and arterial endothelial function in adults with Type 1 diabetes mellitus Diabet. Med. 16 1999 62 66
108. J.J. McGuire, H. Ding, and C.R. Triggle Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s) Can. J. Physiol Pharmacol. 79 2001 443 470
109. K.P. Mellwig, D. Baller, U. Gleichmann, D. Moll, S. Betker, R. Weise, and G. Notohamiprodjo Improvement of coronary vasodilatation capacity through single LDL apheresis Atherosclerosis 139 1998 173 178
110. G. Mercuro, S. Zoncu, F. Saiu, C. Sarais, and G.M. Rosano Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels Am. J. Cardiol. 90 2002 747 750
111. J. Millgard, A. Hagg, M. Sarabi, and L. Lind Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertensive patients J. Hum. Hypertens. 12 1998 511 516
112. M.G. Modena, L. Bonetti, F. Coppi, F. Bursi, and R. Rossi Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women J. Am. Coll. Cardiol. 40 2002 505 510
113. S. Moncada, and A. Higgs The l-arginine-nitric oxide pathway N. Engl. J. Med. 329 1993 2002 2012
114. S.H. Monnink, P.L. van Haelst, A.J. van Boven, E.S. Stroes, R.A. Tio, T.W. Plokker, A.J. Smit, N.J. Veeger, H.J. Crijns, and W.H. van Gilst Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests J. Investig. Med. 50 2002 19 24
115. MRC/BHF Heart Protection Study Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 23 33
116. M.J. Mullen, P. Clarkson, A.E. Donald, H. Thomson, S.A. Thorne, A.J. Powe, T. Furuno, T. Bull, and J.E. Deanfield Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study J. Am. Coll. Cardiol. 31 1998 1330 1335
117. M.J. Mullen, D. Wright, A.E. Donald, S. Thorne, H. Thomson, and J.E. Deanfield Atorvastatin but not l-arginine improves endothelial function in type I diabetes mellitus: a double-blind study J. Am. Coll. Cardiol. 36 2000 410 416
118. E.G. Nabel, P. Ganz, J.B. Gordon, R.W. Alexander, and A.P. Selwyn Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test Circulation 77 1988 43 52
119. L. Nagy, J. Tarjan, M. Samoczi, I. Kovacs, and J. Takacs Effect of benazepril on endothelial function in previously untreated hypertensive patients. The Working Group of Cardiology of the Academic Committee of Veszprem, Hungary Am. J. Ther. 5 1998 233 236
120. H.D. Nelson, L.L. Humphrey, P. Nygren, S.M. Teutsch, and J.D. Allan Postmenopausal hormone replacement therapy: scientific review JAMA 288 2002 872 881
121. T. Neunteufl, R. Katzenschlager, A. Hassan, U. Klaar, S. Schwarzacher, D. Glogar, P. Bauer, and F. Weidinger Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease Atherosclerosis 129 1997 111 118
122. T. Neunteufl, K. Kostner, R. Katzenschlager, M. Zehetgruber, G. Maurer, and F. Weidinger Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men J. Am. Coll. Cardiol. 32 1998 711 716
123. T. Neunteufl, S. Heher, R. Katzenschlager, G. Wolfl, K. Kostner, G. Maurer, and F. Weidinger Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain Am. J. Cardiol. 86 2000 207 210
124. A. Nitenberg, I. Antony, E. Aptecar, F. Arnoult, and G. Lerebours Impairment of flow-dependent coronary dilation in hypertensive patients. Demonstration by cold pressor test induced flow velocity increase Am. J. Hypertens. 8 1995 13S 18S
125. A. Nitenberg, P. Valensi, R. Sachs, E. Cosson, J.R. Attali, and I. Antony Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors Diabetes Care 27 2004 208 215
126. J.P. Noon, B.R. Walker, M.F. Hand, and D.J. Webb Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin Cardiovasc. Res. 38 1998 480 484
127. D. Novosel, M.G. Lang, G. Noll, and T.F. Luscher Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone rat: effects of therapy with verapamil and trandolapril alone and in combination J. Cardiovasc. Pharmacol. 24 1994 979 985
128. G. O'Driscoll, D. Green, J. Rankin, K. Stanton, and R. Taylor Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus J. Clin. Invest. 100 1997 678 684
129. G. O'Driscoll, D. Green, and R.R. Taylor Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1997 1126 1131
130. G. O'Driscoll, D. Green, A. Maiorana, K. Stanton, F. Colreavy, and R. Taylor Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus J. Am. Coll. Cardiol. 33 1999 1506 1511
131. Y. Ohara, T.E. Peterson, and D.G. Harrison Hypercholesterolemia increases endothelial superoxide anion production J. Clin. Invest. 91 1993 2546 2551
132. H. Omori, H. Nagashima, Y. Tsurumi, A. Takagi, N. Ishizuka, N. Hagiwara, M. Kawana, and H. Kasanuki Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects Br. J. Clin. Pharmacol. 54 2002 395 399
133. R.M. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from l-arginine Nature 333 1988 664 666
134. J.A. Panza, A.A. Quyyumi, J.E. Brush Jr., and S.E. Epstein Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension N. Engl. J. Med. 323 1990 22 27
135. J.A. Panza, C.E. Garcia, C.M. Kilcoyne, A.A. Quyyumi, and R.O. Cannon III Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway Circulation 91 1995 1732 1738
136. W.F. Penny, O. Ben Yehuda, K. Kuroe, J. Long, A. Bond, V. Bhargava, J.F. Peterson, M. McDaniel, J. Juliano, J.L. Witztum, J. Ross Jr., and K.L. Peterson Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein J. Am. Coll. Cardiol. 37 2001 766 774
137. F. Perticone, R. Ceravolo, R. Maio, C. Cloro, M. Candigliota, A. Scozzafava, A. Mongiardo, P. Mastroroberto, M. Chello, and P.L. Mattioli Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients Atherosclerosis 152 2000 511 518
138. F. Perticone, R. Ceravolo, A. Pujia, G. Ventura, S. Iacopino, A. Scozzafava, A. Ferraro, M. Chello, P. Mastroroberto, P. Verdecchia, and G. Schillaci Prognostic significance of endothelial dysfunction in hypertensive patients Circulation 104 2001 191 196
139. A. Prasad, S. Narayanan, S. Husain, F. Padder, M. Waclawiw, N. Epstein, and A.A. Quyyumi Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition Circulation 102 2000 35 41
140. A. Prasad, T. Tupas-Habib, W.H. Schenke, R. Mincemoyer, J.A. Panza, M.A. Waclawin, S. Ellahham, and A.A. Quyyumi Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis Circulation 101 2000 2349 2354
141. A.A. Quyyumi Effects of aspirin on endothelial dysfunction in atherosclerosis Am. J. Cardiol. 82 1998 31S 33S
142. A.A. Quyyumi, N. Dakak, N.P. Andrews, S. Husain, S. Arora, D.M. Gilligan, J.A. Panza, and R.O. Cannon III Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis J. Clin. Invest. 95 1995 1747 1755
143. O.T. Raitakari, and D.S. Celermajer Flow-mediated dilatation Br. J. Clin. Pharmacol. 50 2000 397 404
144. S. Rajagopalan, S. Kurz, T. Munzel, M. Tarpey, B.A. Freeman, K.K. Griendling, and D.G. Harrison Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone J. Clin. Invest. 97 1996 1916 1923
145. R.M. Rapoport, and F. Murad Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP Circ. Res. 52 1983 352 357
146. R.M. Rapoport, M.B. Draznin, and F. Murad Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation Nature 306 1983 174 176
147. M.N. Rashid, and R.C. Touchon Dyslipidemia evaluated by brachial artery vasoactivity: a case study of eight patients W. Va. Med. J. 95 1999 175 179
148. E. Rodrigo, R. Maeso, R. Munoz-Garcia, J. Navarro-Cid, L.M. Ruilope, V. Cachofeiro, and V. Lahera Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril J. Hypertens. 15 1997 613 618
149. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1999 115 126
150. G.M. Rubanyi The role of endothelium in cardiovascular homeostasis and diseases J. Cardiovasc. Pharmacol. 22 Suppl. 4 1993 S1 S14
151. A. Saitta, D. Altavilla, D. Cucinotta, N. Morabito, N. Frisina, F. Corrado, R. D'Anna, A. Lasco, G. Squadrito, A. Gaudio, F. Cancellieri, V. Arcoraci, and F. Squadrito Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women Arterioscler. Thromb. Vasc. Biol. 21 2001 1512 1519
152. V. Schachinger, M.B. Britten, and A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
153. T.H. Schindler, B. Hornig, P.T. Buser, M. Olschewski, N. Magosaki, M. Pfisterer, E.U. Nitzsche, U. Solzbach, and H. Just Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms Arterioscler. Thromb. Vasc. Biol. 23 2003 495 501
154. P. Schoeffter, R. Dion, and T. Godfraind Modulatory role of the vascular endothelium in the contractility of human isolated internal mammary artery Br. J. Pharmacol. 95 1988 531 543
155. C. Seiler, O.M. Hess, M. Buechi, T.M. Suter, and H.P. Krayenbuehl Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries Circulation 88 1993 2139 2148
156. W.H. Sheu, B.L. Juang, Y.T. Chen, and W.J. Lee Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia Diabetes Care 22 1999 1224 1225
157. W.H. Sheu, Y.T. Chen, and W.J. Lee Improvement in endothelial dysfunction with LDL cholesterol level <80 mg/dl in type 2 diabetic patients Diabetes Care 24 2001 1499 1501
158. N. Shiode, M. Kato, A. Hiraoka, T. Yamagata, H. Matsuura, and G. Kajiyama Impaired endothelium-dependent vasodilation of coronary resistance vessels in hypercholesterolemic patients Intern. Med. 35 1996 89 93
159. L.A. Simons, D. Sullivan, J. Simons, and D.S. Celermajer Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia Atherosclerosis 137 1998 197 203
160. J.H. Stein, C.M. Carlsson, K. Papcke-Benson, S.E. Aeschlimann, A. Bodemer, M. Carnes, and P.E. McBride The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia J. Am. Coll. Cardiol. 38 2001 1806 1813
161. E.S. Stroes, H.A. Koomans, T.W. de Bruin, and T.J. Rabelink Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication Lancet 346 1995 467 471
162. E. Stroes, J. Kastelein, F. Cosentino, W. Erkelens, R. Wever, H. Koomans, T. Luscher, and T. Rabelink Tetrahydrobiopterin restores endothelial function in hypercholesterolemia J. Clin. Invest. 99 1997 41 46
163. J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes Jr., and A. Lerman Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction Circulation 101 2000 948 954
164. S. Taddei, A. Virdis, L. Ghiadoni, P. Mattei, and A. Salvetti Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients J. Hypertens. 16 1998 447 456
165. S. Tadjkarimi, G.S. O'Neil, T.N. Luu, S.P. Allen, C.J. Schyns, A.H. Chester, and M.H. Yacoub Comparison of cyclic GMP in human internal mammary artery and saphenous vein: implications for coronary artery bypass graft patency Cardiovasc. Res. 26 1992 297 300
166. B. Takase, A. Uehata, T. Akima, T. Nagai, T. Nishioka, A. Hamabe, K. Satomura, F. Ohsuzu, and A. Kurita Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease Am. J. Cardiol. 82 1998 1535 1538
167. M. Takemoto, and J.K. Liao Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors Arterioscler. Thromb. Vasc. Biol. 21 2001 1712 1719
168. O. Tamai, H. Matsuoka, H. Itabe, Y. Wada, K. Kohno, and T. Imaizumi Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans Circulation 95 1997 76 82
169. P.V. Targonski, P.O. Bonneti, G.M. Pumper, S.T. Higano, D.R. Holmes, and A. Lerman Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events Circulation 107 2003 2805 2809
170. R.A. Tio, S.H. Monnink, G. Amoroso, G.A. Jessurun, N. Veeger, C. Volkers, R. Hautvast, E.S. Tan, W.H. van Gilst, and A.J. van Boven Safety evaluation of routine intracoronary acetylcholine infusion in patients undergoing a first diagnostic coronary angiogram J. Investig. Med. 50 2002 133 139
171. L.M. Title, P.M. Cummings, K. Giddens, J.J. Genest Jr., and B.A. Nassar Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease J. Am. Coll. Cardiol. 36 2000 758 765
172. J.O. Toikka, M. Ahotupa, J.S. Viikari, H. Niinikoski, M. Taskinen, K. Irjala, J.J. Hartiala, and O.T. Raitakari Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men Atherosclerosis 147 1999 133 138
173. C.B. Treasure, S.V. Manoukian, J.L. Klein, J.A. Vita, E.G. Nabel, G.H. Renwick, A.P. Selwyn, R.W. Alexander, and P. Ganz Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients Circ. Res. 71 1992 776 781
174. C.B. Treasure, J.L. Klein, W.S. Weintraub, J.D. Talley, M.E. Stillabower, A.S. Kosinski, J. Zhang, S.J. Boccuzzi, J.C. Cedarholm, and R.W. Alexander Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N. Engl. J. Med. 332 1995 481 487
175. T. Tsunekawa, T. Hayashi, H. Kano, D. Sumi, H. Matsui-Hirai, N.K. Thakur, K. Egashira, and A. Iguchi Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days Circulation 104 2001 376 379
176. M.A. van de Ree, M.V. Huisman, F.H. de Man, J.C. van der Vijver, A.E. Meinders, and G.J. Blauw Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin Cardiovasc. Res. 52 2001 299 305
177. J.R. Vane, E.E. Anggard, and R.M. Botting Regulatory functions of the vascular endothelium N. Engl. J. Med. 323 1990 27 36
178. R.W. van Etten, E.J. de Koning, M.L. Honing, E.S. Stroes, C.A. Gaillard, and T.J. Rabelink Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes Arterioscler. Thromb. Vasc. Biol. 22 2002 799 804
179. P.L. van Haelst, J.J. van Doormaal, F.W. Asselbergs, A.M. Van Roon, N.J. Veeger, M.M. Henneman, A.J. Smit, J.W. Cohen Tervaert, J.F. May, and R.O. Gans Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia Clin. Sci. (Lond.) 104 2003 627 632
180. P.M. Vanhoutte Endothelial dysfunction in hypertension J. Hypertens. Suppl. 14 1996 S83 S93
181. P.M. Vanhoutte, C.M. Boulanger, S.C. Illiano, T. Nagao, M. Vidal, and J.V. Mombouli Endothelium-dependent effects of converting-enzyme inhibitors J. Cardiovasc. Pharmacol. 22 Suppl. 5 1993 S10 S16
182. F.V. van Venrooij, M.A. van de Ree, M.L. Bots, R.P. Stolk, M.V. Huisman, and J.D. Banga Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial Diabetes Care 25 2002 1211 1216
183. J.A. Vita, C.B. Treasure, E.G. Nabel, J.M. McLenachan, R.D. Fish, A.C. Yeung, V.I. Vekshtein, A.P. Selwyn, and P. Ganz Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease Circulation 81 1990 491 497
184. J.A. Vita, A.C. Yeung, M. Winniford, J.M. Hodgson, C.B. Treasure, J.L. Klein, S. Werns, M. Kern, D. Plotkin, W.J. Shih, Y. Mitchel, and P. Ganz Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease Circulation 102 2000 846 851
185. J.A. Vita, N. Gokce, S.J. Duffy, D. Kahn, D. Tomasian, J. Palmisano, S. Thomas, M. Holbrook, and J.F. Keaney Jr. Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease Am. J. Cardiol. 91 2003 857 860
186. R.A. Vogel, M.C. Corretti, and G.D. Plotnick Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men Am. J. Cardiol. 77 1996 37 40
187. G.O. von Mering, C.B. Arant, T.R. Wessel, S.P. McGorray, C.N. Merz, B.L. Sharaf, K.M. Smith, M.B. Olson, B.D. Johnson, G. Sopko, E.M. Handberg, C.J. Pepine, and R.A. Kerensky Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation 109 2004 722 725
188. A.A. Voors, M. Oosterga, H. Buikema, J.F. May, J.G. Grandjean, A. van Buiten, and W.H. van Gilst Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery Cardiovasc. Res. 34 1997 568 574
189. S. Wassmann, A. Faul, B. Hennen, B. Scheller, M. Bohm, and G. Nickenig Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function Circ. Res. 93 2003 e98 e103
190. S. Wassmann, N. Ribaudo, A. Faul, U. Laufs, M. Bohm, and G. Nickenig Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl Am. J. Cardiol. 93 2004 84 88
191. G.S. Werner, V. Wiegand, and H. Kreuzer Effect of acetylcholine on arterial and venous grafts and coronary arteries in patients with coronary artery disease Eur. Heart J. 11 1990 127 137
192. I.B. Wilkinson, and D.J. Webb Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications Br. J. Clin. Pharmacol. 52 2001 631 646
193. H.W. Wilmink, J.D. Banga, M. Hijmering, W.D. Erkelens, E.S. Stroes, and T.J. Rabelink Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function J. Am. Coll. Cardiol. 34 1999 140 145
194. S. Wolfrum, K.S. Jensen, and J.K. Liao Endothelium-dependent effects of statins Arterioscler. Thromb. Vasc. Biol. 23 2003 729 736
195. Z.H. Yang, D. Diederich, K. Schneider, R. Siebenmann, P. Stulz, L. von Segesser, M. Turina, F.R. Buhler, and T.F. Luscher Endothelium-derived relaxing factor and protection against contractions induced by histamine and serotonin in the human internal mammary artery and in the saphenous vein Circulation 80 1989 1041 1048
196. S. Yusuf, G. Dagenais, J. Pogue, J. Bosch, and P. Sleight Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N. Engl. J. Med. 342 2000 154 160
197. A.M. Zeiher, H. Drexler, H. Wollschlaeger, B. Saurbier, and H. Just Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium J. Am. Coll. Cardiol. 14 1989 1181 1190
198. A.M. Zeiher, H. Drexler, H. Wollschlager, and H. Just Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis Circulation 84 1991 1984 1992
199. A.M. Zeiher, H. Drexler, H. Wollschlager, and H. Just Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis Circulation 83 1991 391 401